A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
用于对基因组改变作为癌症精准医疗靶点进行排序的框架:ESMO分子靶点临床可操作性量表(ESCAT)
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdy263
Mateo, J; Chakravarty, D; Dienstmann, R; Jezdic, S; Gonzalez-Perez, A; Lopez-Bigas, N; Ng, C K Y; Bedard, P L; Tortora, G; Douillard, J-Y; Van Allen, E M; Schultz, N; Swanton, C; André, F; Pusztai, L